| ADC | Antibody drug conjuagte |
| CD8 | Cluster of differentiation 8 |
| CPS | Immune checkpoint signature |
| CTLA-4 | Cytotoxic T-lymphocyte-associated protein 4 |
| ER | Estrogen receptor |
| HER2 | Human epidermal growth factor receptor 2 |
| HR | Hazard ratio |
| LAG-3 | Lymphocyte activation gene-3 |
| ICP | Immune checkpoints |
| ICPi | Immune checkpoint inhibitors |
| MFS | Metastasis-free survival |
| NACT | Neoadjuvant cytotoxic therapy |
| OS | Overall survival |
| PD-1 | Programmed cell-death protein 1 |
| PD-L1 | Programmed death-ligand 1 |
| PR | Progesteron receptor |
| RFS | Recurrence-free survival |
| TILs | Tumor-infiltrating lymphocytes |
| TNBC | Triple-negative breast cancer |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.